| 000 | 01791 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250511212733.0 | ||
| 264 | 0 | _c19911108 | |
| 008 | 199111s 0 0 eng d | ||
| 022 | _a0167-594X | ||
| 024 | 7 |
_a10.1007/BF00166998 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCorden, B J | |
| 245 | 0 | 0 |
_aCisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors. _h[electronic resource] |
| 260 |
_bJournal of neuro-oncology _cAug 1991 |
||
| 300 |
_a57-63 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aAstrocytoma _xdrug therapy |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCerebellar Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 |
_aEpendymoma _xdrug therapy |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlioma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMedulloblastoma _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 |
_aPinealoma _xdrug therapy |
| 650 | 0 | 4 | _aProbability |
| 650 | 0 | 4 | _aPrognosis |
| 700 | 1 | _aStrauss, L C | |
| 700 | 1 | _aKillmond, T | |
| 700 | 1 | _aCarson, B S | |
| 700 | 1 | _aWharam, M D | |
| 700 | 1 | _aKumar, A J | |
| 700 | 1 | _aPiantadosi, S | |
| 700 | 1 | _aRobb, P A | |
| 700 | 1 | _aPhillips, P C | |
| 773 | 0 |
_tJournal of neuro-oncology _gvol. 11 _gno. 1 _gp. 57-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00166998 _zAvailable from publisher's website |
| 999 |
_c1925844 _d1925844 |
||